$ULBI

ULTRALIFE CORP (ULBI): Submission of Matters to a Vote of Security Holders

ULTRALIFE CORP (ULBI) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. ulbi20260723_8k.htm false 0000875657 0000875657 2026-07-23 2026-07-23 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 July 23, 2026 Date of Report (Date of Earli

Original reporting
Published Jul 23, 2026, 8:27 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 23, 2026, 8:29 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefCorporate actions
Primary signal
$ULBI
Neutral
high confidence
Mentioned
$ULBI
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$ULBINeutralLow
01

Why it matters

The filing confirms the board’s composition for the next term, ratifies the independent auditor for 2026, and records advisory votes on executive compensation and the preferred frequency (3 years).

02

Market read

This is a routine governance disclosure with no new guidance, deal, or enforcement action; it is unlikely to drive material repricing.

03

What to watch

Traders may still monitor whether any director changes or auditor ratification signal broader governance shifts, but this 8-K does not provide such qualitative changes beyond the vote counts.

Relevance 6/10Novelty 2/10Timing: Filed after the July 22, 2026 annual meeting results, for same-day governance record.

Background

Ultralife Corporation filed an SEC Form 8-K under Item 5.07 to report results from its July 22, 2026 annual meeting of stockholders.

Company-level read

Ticker impact

$ULBINeutralHigh confidence
Context

Ultralife reported 2026 annual meeting voting results, including director elections, auditor ratification, and executive-compensation advisory votes.

Expected impact

Limited near-term impact; any reaction is likely muted and short-lived.

Evidence & confidence

Item 5.07 is a standard post-meeting disclosure. The text provides vote tallies and the board’s decision to hold executive-compensation advisory votes every three years, which is governance-related and not a direct earnings or balance-sheet change.

Market effects

No clear sector read-through; this is company-specific governance disclosure.

None indicated.

None indicated.

Counterpoint

If governance outcomes were previously contested, the vote could reduce uncertainty, but the filing still lacks any new strategic or financial commitments.

Key entities

  • Ultralife Corporation

    Company reporting annual meeting voting results on directors, auditor ratification, and executive-compensation advisory matters.

  • WithumSmith+Brown, PC

    Independent registered public accounting firm ratified for 2026 by shareholder vote.

Related articles

$ENSHighAI 9/10

EnerSys to Acquire Ultralife for $16 Per Share in Cash

EnerSys (ENS) agreed to acquire Ultralife for $16 per share in cash. The deal, subject to regulatory approvals, includes support from shareholders holding 40.3% of Ultralife's shares. The tender offer is expected to start within 10 business days and may close by April 27, 2027, with possible extensions.

$ENSHighAI 9/10

EnerSys to acquire Ultralife for $320 million in cash

EnerSys (ENS) agreed to acquire Ultralife (ULBI) for $320 million in cash, including debt. Ultralife shareholders will receive $16.00 per share, a 166% premium over Monday's closing price. The deal, approved by both boards, is expected to close in Q1 2027. EnerSys will finance the acquisition with available cash. Both companies' CEOs cited strategic benefits and value creation.

$ULBIMedAI 8/10

Ultralife (ULBI) Q2 2026 Earnings Call Transcript

Ultralife (ULBI) reported Q2 FY2026 revenue of $47.9 million, down 1.3% year over year, with GAAP EPS of $0.15. Gross margin rose to 28.9% on a 500 bps increase, aided by a $1.1 million IEEPA tariff refund. Backlog hit a record $117.5 million, up 39% from a year earlier, and July backlog neared $130 million.

$ULBIMed

Ultralife Corporation Reports Second Quarter Results

ULTRALIFE CORP (ULBI) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Ultralife Corporation Reports Second Quarter Results NEWARK, N.Y. – August 7, 2026 -- Ultralife Corporation (NASDAQ: ULBI) reported operating results for the second quarter ended June 30, 2026 with the following results: ● Sales of $47.9 million compared to $48.6 mil